Ariceum Therapeutics

1 follower


Ariceum Therapeutics is a privately held radiopharmaceutical firm in the clinical stage that specializes in the detection and targeted treatment of aggressive malignancies, such as neuroendocrine and other hard-to-treat cancers.177Lu-satoreotide tetraxetan (Satoreotide), the company's primary target... Read more

Headquarters

Berlin, Germany

Employees

11-50

Links


Org chart

Manfred Ruediger
CEO of Ariceum Therapeutics GmbH
Collapse
Anika Jäkel
Senior Director
Dennis MEWIS
Head Of Laboratory - CMC & Radiopharmaceutical R&D
Germo Gericke
Chief Medical Officer
Serge SAGODIRA
Chief Business Officer
Brigitta Voss
Head Program And Portfolio Management
Aaron Block, MBA
Senior Director Business Development
Erwin Bachmohr
Consultant, acting as Head of Procurement & Supply Chain